Periodical
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial
العنوان: | Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial |
---|---|
المؤلفون: | Roof, Elizabeth, Deal, Cheri L, McCandless, Shawn E, Cowan, Ronald L, Miller, Jennifer L, Hamilton, Jill K, Roeder, Elizabeth R, McCormack, Shana E, Roshan Lal, Tamanna R, Abdul-Latif, Hussein D, Haqq, Andrea M, Obrynba, Kathryn S, Torchen, Laura C, Vidmar, Alaina P, Viskochil, David H, Chanoine, Jean-Pierre, Lam, Carol K L, Pierce, Melinda J, Williams, Laurel L, Bird, Lynne M, Butler, Merlin G, Jensen, Diane E, Myers, Susan E, Oatman, Oliver J, Baskaran, Charumathi, Chalmers, Laura J, Fu, Cary, Alos, Nathalie, McLean, Scott D, Shah, Ajay, Whitman, Barbara Y, Blumenstein, Brent A, Leonard, Sarah F, Ernest, Jessica P, Cormier, Joseph W, Cotter, Sara P, Ryman, Davis C |
المصدر: | The Journal of Clinical Endocrinology & Metabolism; July 2023, Vol. 108 Issue: 7 p1696-1708, 13p |
قاعدة البيانات: | Supplemental Index |
تدمد: | 0021972X 19457197 |
---|---|
DOI: | 10.1210/clinem/dgad015 |